Antigen-based therapy and immune-regulation in experimental autoimmune encephalomyelitis

Mandy J McGeachy, Richard O'Connor, Leigh A Stephens, Stephen M Anderton

Research output: Contribution to journalArticlepeer-review


Experimental autoimmune encephalomyelitis is a long-established mouse model of multiple sclerosis. The requirements for autoreactive T-cell activation in this disease have been characterized extensively and novel strategies for immune-intervention are being developed continually. Notably, identification of immunodominant T-cell epitopes allows the induction of T-cell tolerance with synthetic peptides. Several transgenic mouse lines that express transgenic T-cell receptors recognizing myelin autoantigenic epitopes have been developed. These allow adoptive transfer studies to analyse the activation of naive autoreactive T cells in vivo during the induction of tolerance vs immunity. More recently, our attention has focused on immune mechanisms underlying the natural recovery from disease. Sampling of the lymphoid cell infiltrate within the central nervous system has identified the accumulation of regulatory T cells in the target organ during this period of resolution.
Original languageEnglish
Pages (from-to)313-26
Number of pages14
JournalMethods in Molecular Biology
Publication statusPublished - 2007


Dive into the research topics of 'Antigen-based therapy and immune-regulation in experimental autoimmune encephalomyelitis'. Together they form a unique fingerprint.

Cite this